Points Plus

← Back to Cases

FDA v. R. J. Reynolds Vapor Co.

Docket: 23-1187 Decision Date: 2025-06-20
View Official PDF
This links to the official slip opinion PDF.
How to read this page

Below are plain-language sections to help you understand what the Court decided in FDA v. R. J. Reynolds Vapor Co. and why it matters. Quotes are taken from the syllabus (the Court’s short summary at the start of the opinion).

Summary

A short, plain-English overview of FDA v. R. J. Reynolds Vapor Co..

The Supreme Court addressed whether retailers could seek judicial review of the FDA's denial of an e-cigarette product application under the Tobacco Control Act. The Court found that retailers are 'adversely affected' by such denials, allowing them to petition for review. This decision affirmed the Fifth Circuit's ruling that venue was proper for the retailers' challenge.

Holding

The single most important “bottom line” of what the Court decided in FDA v. R. J. Reynolds Vapor Co..

The Court held that retailers who would sell a new tobacco product if not for the FDA's denial order may seek judicial review under § 387l(a)(1).

Constitutional Concepts

These are the Constitution-related themes that appear in FDA v. R. J. Reynolds Vapor Co.. Click a concept to see other cases that involve the same idea.

  • Why Administrative Law is relevant to FDA v. R. J. Reynolds Vapor Co.

    The case involves the interpretation of statutory language regarding who is 'adversely affected' by an agency's decision, which is a key aspect of administrative law.

    Syllabus excerpt (verbatim)
    To invoke a statutory cause of action, a plaintiff must be within the 'zone of interests' that the statute protects.
  • Why Judicial Review is relevant to FDA v. R. J. Reynolds Vapor Co.

    The case concerns the right of retailers to seek judicial review of an FDA order, which is central to the Court's decision.

    Syllabus excerpt (verbatim)
    Retailers who would sell a new tobacco product if not for the FDA's denial order may seek judicial review of that order under § 387l(a)(1).
  • Why Standing is relevant to FDA v. R. J. Reynolds Vapor Co.

    The Court's decision hinges on whether the retailers are considered 'adversely affected' and thus have standing to challenge the FDA's decision.

    Syllabus excerpt (verbatim)
    The retailers fit the bill. If the FDA denies an application, the retailers lose the opportunity to profit from the sale of the new tobacco product.

Key Quotes

Short excerpts from the syllabus in FDA v. R. J. Reynolds Vapor Co. that support the summary and concepts above.

  • Retailers who would sell a new tobacco product if not for the FDA's denial order may seek judicial review of that order under § 387l(a)(1).
  • The Court interprets 'adversely affected' in the TCA against this backdrop.
  • Congress's use of 'any' suggests that a denial order can adversely affect multiple persons.

Leave a Reply

Your email address will not be published. Required fields are marked *